{"id":378951,"date":"2020-11-11T16:08:15","date_gmt":"2020-11-11T21:08:15","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=378951"},"modified":"2020-11-11T16:08:15","modified_gmt":"2020-11-11T21:08:15","slug":"qiagen-launches-portable-digital-sars-cov-2-antigen-test-that-can-accurately-analyze-over-30-samples-per-hour","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-portable-digital-sars-cov-2-antigen-test-that-can-accurately-analyze-over-30-samples-per-hour\/","title":{"rendered":"QIAGEN Launches Portable Digital SARS-CoV-2 Antigen Test That Can Accurately Analyze Over 30 Samples Per Hour"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>QIAGEN Launches Portable Digital SARS-CoV-2 Antigen Test That Can Accurately Analyze Over 30 Samples Per Hour<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li><b><i>QIAreach\u2122 SARS-CoV-2 Antigen Test,<\/i> developed in partnership with Ellume, is an important step towards decentralized mass screening by processing samples in 2\u201315 minutes<\/b><\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li><b>Digital results for dozens of samples per hour and the ability to process antibody tests in parallel, setting new standards in scalability and flexibility <\/b><\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li><b>Test submitted to FDA for Emergency Use Authorization for US, CE-IVD marking for European Union and other markets expected by year\u2019s end<\/b><\/li>\n<\/ul>\n<p>HILDEN, Germany &amp; GERMANTOWN, Md.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nQIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) has started commercialization of a portable digital test in the United States that can be used by laboratories to detect SARS-CoV-2 antigens in people with active infections in 2-15 minutes. A point of care (POC) claim will be added and EUA amended later this year.\n<\/p>\n<p>\nThe <i>QIAreach\u2122 SARS-CoV-2 Antigen Test, <\/i>developed in partnership with the Australian digital diagnostics company Ellume, sets new standards in scalability, validation and flexibility by processing more than 30 swab samples per hour, providing digital test results that do not require subjective interpretation, and allowing antibody tests to run simultaneously with antigen tests. This flexibility will be particularly valuable when vaccines are introduced.\n<\/p>\n<p>\nQIAGEN has begun marketing and distributing <i>QIAreach\u2122 SARS-CoV-2 Antigen Test<\/i> in the United States after applying for FDA emergency use authorization (EUA) for symptomatic patients. CE-IVD registration for European Union and other markets is expected as early as by the end of the year.\n<\/p>\n<p>\n\u201cAs existing approaches often lack scalability and accuracy, antigen testing is playing an increasingly important role in national testing strategies as a complementary tool to PCR, the gold-standard for detecting active COVID-19 infections,\u201d said Thierry Bernard, Chief Executive Officer of QIAGEN. \u201cQIAreach SARS-CoV Antigen is a fast, digital and easy to use test that makes use of sensitive nanoparticle technology from Ellume. In as little as two minutes it allows objective reading of test results that provide clear qualitative interpretation. And it addresses the growing need for higher throughput testing for SARS-CoV-2 antigen by processing up to eight tests per hub simultaneously.\u201d\n<\/p>\n<p>\nPlease find the full press release <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fcorporate.qiagen.com%2Fnewsroom%2Fpress-releases%2F2020%2F20201111_qiareach_antigen_eua&amp;esheet=52325266&amp;newsitemid=20201111005760&amp;lan=en-US&amp;anchor=here&amp;index=1&amp;md5=430c15e9c63c1abbce8662cd0549c827\">here<\/a><\/p>\n<p class=\"bwalignc\">\n###\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201111005760r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20201111005760\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20201111005760\/en\/<\/a><\/span><\/p>\n<p><b>QIAGEN<\/p>\n<p>Investor Relations<br \/>\n<br \/><\/b>e-mail: <a rel=\"nofollow\" href=\"mailto:ir@QIAGEN.com\">ir@QIAGEN.com<br \/>\n<\/a><\/p>\n<p>John Gilardi<br \/>\n<br \/>+49 2103 29 11711<\/p>\n<p>Phoebe Loh<br \/>\n<br \/>+49 2103 29 11457<br \/>\n<br \/><b><br \/>Public Relations<br \/>\n<\/b><br \/>e-mail: <a rel=\"nofollow\" href=\"mailto:pr@QIAGEN.com\">pr@QIAGEN.com<br \/>\n<\/a><br \/><b><br \/><\/b>Thomas Theuringer<br \/>\n<br \/>+49 2103 29 11826<\/p>\n<p>Robert Reitze<br \/>\n<br \/>+49 2103 29 11676\n<\/p>\n<p><b>KEYWORDS:<\/b> Maryland Switzerland United States Austria North America Europe Germany<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Medical Devices Health Infectious Diseases Research Science Biotechnology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\" \/>\n","protected":false},"excerpt":{"rendered":"<p>QIAGEN Launches Portable Digital SARS-CoV-2 Antigen Test That Can Accurately Analyze Over 30 Samples Per Hour QIAreach\u2122 SARS-CoV-2 Antigen Test, developed in partnership with Ellume, is an important step towards decentralized mass screening by processing samples in 2\u201315 minutes Digital results for dozens of samples per hour and the ability to process antibody tests in parallel, setting new standards in scalability and flexibility Test submitted to FDA for Emergency Use Authorization for US, CE-IVD marking for European Union and other markets expected by year\u2019s end HILDEN, Germany &amp; GERMANTOWN, Md.&#8211;(BUSINESS WIRE)&#8211; QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) has started commercialization of a portable digital test in the United States that can be used by laboratories to detect SARS-CoV-2 antigens &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-portable-digital-sars-cov-2-antigen-test-that-can-accurately-analyze-over-30-samples-per-hour\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;QIAGEN Launches Portable Digital SARS-CoV-2 Antigen Test That Can Accurately Analyze Over 30 Samples Per Hour&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-378951","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>QIAGEN Launches Portable Digital SARS-CoV-2 Antigen Test That Can Accurately Analyze Over 30 Samples Per Hour - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-portable-digital-sars-cov-2-antigen-test-that-can-accurately-analyze-over-30-samples-per-hour\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"QIAGEN Launches Portable Digital SARS-CoV-2 Antigen Test That Can Accurately Analyze Over 30 Samples Per Hour - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"QIAGEN Launches Portable Digital SARS-CoV-2 Antigen Test That Can Accurately Analyze Over 30 Samples Per Hour QIAreach\u2122 SARS-CoV-2 Antigen Test, developed in partnership with Ellume, is an important step towards decentralized mass screening by processing samples in 2\u201315 minutes Digital results for dozens of samples per hour and the ability to process antibody tests in parallel, setting new standards in scalability and flexibility Test submitted to FDA for Emergency Use Authorization for US, CE-IVD marking for European Union and other markets expected by year\u2019s end HILDEN, Germany &amp; GERMANTOWN, Md.&#8211;(BUSINESS WIRE)&#8211; QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) has started commercialization of a portable digital test in the United States that can be used by laboratories to detect SARS-CoV-2 antigens &hellip; Continue reading &quot;QIAGEN Launches Portable Digital SARS-CoV-2 Antigen Test That Can Accurately Analyze Over 30 Samples Per Hour&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-portable-digital-sars-cov-2-antigen-test-that-can-accurately-analyze-over-30-samples-per-hour\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-11T21:08:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201111005760r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-launches-portable-digital-sars-cov-2-antigen-test-that-can-accurately-analyze-over-30-samples-per-hour\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-launches-portable-digital-sars-cov-2-antigen-test-that-can-accurately-analyze-over-30-samples-per-hour\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"QIAGEN Launches Portable Digital SARS-CoV-2 Antigen Test That Can Accurately Analyze Over 30 Samples Per Hour\",\"datePublished\":\"2020-11-11T21:08:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-launches-portable-digital-sars-cov-2-antigen-test-that-can-accurately-analyze-over-30-samples-per-hour\\\/\"},\"wordCount\":429,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-launches-portable-digital-sars-cov-2-antigen-test-that-can-accurately-analyze-over-30-samples-per-hour\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201111005760r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-launches-portable-digital-sars-cov-2-antigen-test-that-can-accurately-analyze-over-30-samples-per-hour\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-launches-portable-digital-sars-cov-2-antigen-test-that-can-accurately-analyze-over-30-samples-per-hour\\\/\",\"name\":\"QIAGEN Launches Portable Digital SARS-CoV-2 Antigen Test That Can Accurately Analyze Over 30 Samples Per Hour - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-launches-portable-digital-sars-cov-2-antigen-test-that-can-accurately-analyze-over-30-samples-per-hour\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-launches-portable-digital-sars-cov-2-antigen-test-that-can-accurately-analyze-over-30-samples-per-hour\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201111005760r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2020-11-11T21:08:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-launches-portable-digital-sars-cov-2-antigen-test-that-can-accurately-analyze-over-30-samples-per-hour\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-launches-portable-digital-sars-cov-2-antigen-test-that-can-accurately-analyze-over-30-samples-per-hour\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-launches-portable-digital-sars-cov-2-antigen-test-that-can-accurately-analyze-over-30-samples-per-hour\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201111005760r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201111005760r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-launches-portable-digital-sars-cov-2-antigen-test-that-can-accurately-analyze-over-30-samples-per-hour\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"QIAGEN Launches Portable Digital SARS-CoV-2 Antigen Test That Can Accurately Analyze Over 30 Samples Per Hour\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"QIAGEN Launches Portable Digital SARS-CoV-2 Antigen Test That Can Accurately Analyze Over 30 Samples Per Hour - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-portable-digital-sars-cov-2-antigen-test-that-can-accurately-analyze-over-30-samples-per-hour\/","og_locale":"en_US","og_type":"article","og_title":"QIAGEN Launches Portable Digital SARS-CoV-2 Antigen Test That Can Accurately Analyze Over 30 Samples Per Hour - Market Newsdesk","og_description":"QIAGEN Launches Portable Digital SARS-CoV-2 Antigen Test That Can Accurately Analyze Over 30 Samples Per Hour QIAreach\u2122 SARS-CoV-2 Antigen Test, developed in partnership with Ellume, is an important step towards decentralized mass screening by processing samples in 2\u201315 minutes Digital results for dozens of samples per hour and the ability to process antibody tests in parallel, setting new standards in scalability and flexibility Test submitted to FDA for Emergency Use Authorization for US, CE-IVD marking for European Union and other markets expected by year\u2019s end HILDEN, Germany &amp; GERMANTOWN, Md.&#8211;(BUSINESS WIRE)&#8211; QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) has started commercialization of a portable digital test in the United States that can be used by laboratories to detect SARS-CoV-2 antigens &hellip; Continue reading \"QIAGEN Launches Portable Digital SARS-CoV-2 Antigen Test That Can Accurately Analyze Over 30 Samples Per Hour\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-portable-digital-sars-cov-2-antigen-test-that-can-accurately-analyze-over-30-samples-per-hour\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-11T21:08:15+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201111005760r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-portable-digital-sars-cov-2-antigen-test-that-can-accurately-analyze-over-30-samples-per-hour\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-portable-digital-sars-cov-2-antigen-test-that-can-accurately-analyze-over-30-samples-per-hour\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"QIAGEN Launches Portable Digital SARS-CoV-2 Antigen Test That Can Accurately Analyze Over 30 Samples Per Hour","datePublished":"2020-11-11T21:08:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-portable-digital-sars-cov-2-antigen-test-that-can-accurately-analyze-over-30-samples-per-hour\/"},"wordCount":429,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-portable-digital-sars-cov-2-antigen-test-that-can-accurately-analyze-over-30-samples-per-hour\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201111005760r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-portable-digital-sars-cov-2-antigen-test-that-can-accurately-analyze-over-30-samples-per-hour\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-portable-digital-sars-cov-2-antigen-test-that-can-accurately-analyze-over-30-samples-per-hour\/","name":"QIAGEN Launches Portable Digital SARS-CoV-2 Antigen Test That Can Accurately Analyze Over 30 Samples Per Hour - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-portable-digital-sars-cov-2-antigen-test-that-can-accurately-analyze-over-30-samples-per-hour\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-portable-digital-sars-cov-2-antigen-test-that-can-accurately-analyze-over-30-samples-per-hour\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201111005760r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2020-11-11T21:08:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-portable-digital-sars-cov-2-antigen-test-that-can-accurately-analyze-over-30-samples-per-hour\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-portable-digital-sars-cov-2-antigen-test-that-can-accurately-analyze-over-30-samples-per-hour\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-portable-digital-sars-cov-2-antigen-test-that-can-accurately-analyze-over-30-samples-per-hour\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201111005760r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201111005760r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-launches-portable-digital-sars-cov-2-antigen-test-that-can-accurately-analyze-over-30-samples-per-hour\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"QIAGEN Launches Portable Digital SARS-CoV-2 Antigen Test That Can Accurately Analyze Over 30 Samples Per Hour"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/378951","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=378951"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/378951\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=378951"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=378951"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=378951"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}